Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for ...

A new study finds that fragments of tumor DNA in a patient's bloodstream could show that they are at high risk of a melanoma ...

Study Identifies Subtypes of Fibroblasts in Skin Cancer Nov. 19 ... June 27, 2024 — In many cases of malignant melanoma, the effect of targeted treatment is lost over time.

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was ...

Monitoring circulating tumor DNA levels before and during treatment may predict melanoma recurrence, offering a potential ...

A new anti-cancer vaccine is to be tested on patients with advanced forms of skin cancer ... patients with advanced melanoma access to new, potentially life-saving treatments.” ...

who herself was treated for melanoma, visited the unit. She said: “As someone who has overcome skin cancer, I know that every advancement in treatment brings hope to patients and their families.

The vaccination has already given thousands of patients access to treatment ... vaccine for bowel cancer and is now expanding to include a trial for melanoma. New melanoma skin cancer cases ...

in patients with advanced unresectable melanoma receiving standard-of-care immunotherapy treatments. The incidence of melanoma, a type of skin cancer that develops when pigment-producing cells located ...

The NHS is accelerating its efforts to provide cutting-edge cancer treatments ... new treatment.” Susanna Daniels, chief executive of Melanoma Focus, said: “Melanoma skin cancer can be ...

The three most common malignant skin cancers are basal ... poorer than for non-melanoma skin cancer, although when melanoma is diagnosed at an early stage, treatment is easier and more people ...